Kim et al. verified that anti-inflammatory probiotics, including NK151, NK173, and NK175, alleviated neuroinflammation and colitis by the suppression of the IL-1β or IL-6–10 expression ratio [49]. The gene discussed is IL1B; the disease is colitis.